29.87
price down icon0.17%   -0.05
after-market 시간 외 거래: 30.10 0.23 +0.77%
loading
전일 마감가:
$29.92
열려 있는:
$30.11
하루 거래량:
2.48M
Relative Volume:
1.37
시가총액:
$19.16B
수익:
$2.62B
순이익/손실:
$966.70M
주가수익비율:
19.91
EPS:
1.5004
순현금흐름:
$1.09B
1주 성능:
-8.79%
1개월 성능:
+3.97%
6개월 성능:
+48.39%
1년 성능:
+31.41%
1일 변동 폭
Value
$29.82
$30.21
1주일 범위
Value
$29.57
$33.19
52주 변동 폭
Value
$17.23
$33.65

Genmab Adr Stock (GMAB) Company Profile

Name
명칭
Genmab Adr
Name
전화
-
Name
주소
-
Name
직원
2,639
Name
트위터
@Genmab
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
GMAB's Discussions on Twitter

GMAB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GMAB
Genmab Adr
29.87 18.55B 2.62B 966.70M 1.09B 1.5004
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Genmab Adr Stock (GMAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-23 업그레이드 Guggenheim Neutral → Buy
2025-04-01 다운그레이드 Bernstein Mkt Perform → Underperform
2025-03-11 업그레이드 William Blair Mkt Perform → Outperform
2025-02-13 업그레이드 Leerink Partners Market Perform → Outperform
2024-10-08 개시 Redburn Atlantic Buy
2024-09-04 재개 Morgan Stanley Equal-Weight
2024-08-20 다운그레이드 JP Morgan Overweight → Neutral
2024-07-15 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2024-02-23 업그레이드 BMO Capital Markets Market Perform → Outperform
2024-01-22 다운그레이드 Citigroup Neutral → Sell
2023-12-06 업그레이드 UBS Neutral → Buy
2023-11-10 업그레이드 Deutsche Bank Hold → Buy
2023-11-08 업그레이드 DNB Markets Sell → Buy
2023-10-18 개시 Exane BNP Paribas Underperform
2023-09-06 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-08-24 개시 BTIG Research Buy
2023-07-14 개시 HSBC Securities Buy
2023-05-31 개시 UBS Neutral
2023-05-12 개시 Morgan Stanley Underweight
2022-12-20 다운그레이드 Citigroup Buy → Neutral
2022-11-14 개시 William Blair Mkt Perform
2022-11-11 다운그레이드 Deutsche Bank Buy → Hold
2022-06-24 개시 BMO Capital Markets Market Perform
2022-05-02 개시 Cowen Market Perform
2022-03-16 업그레이드 UBS Neutral → Buy
2022-01-31 업그레이드 H.C. Wainwright Neutral → Buy
2022-01-03 다운그레이드 Guggenheim Buy → Neutral
2021-12-01 개시 Berenberg Sell
2021-09-16 다운그레이드 Jefferies Buy → Hold
2021-09-07 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2021-08-24 다운그레이드 H.C. Wainwright Buy → Neutral
2021-04-20 개시 Deutsche Bank Buy
2021-01-19 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-09-23 다운그레이드 Bryan Garnier Neutral → Sell
2020-09-08 개시 SVB Leerink Mkt Perform
2020-06-25 다운그레이드 Credit Suisse Outperform → Neutral
2020-04-23 개시 Credit Suisse Outperform
2020-02-24 재확인 H.C. Wainwright Buy
2020-01-13 개시 SunTrust Buy
2019-12-12 다운그레이드 Deutsche Bank Buy → Hold
2019-09-13 업그레이드 BofA/Merrill Neutral → Buy
2019-09-12 업그레이드 JP Morgan Neutral → Overweight
2019-08-12 개시 Guggenheim Buy
2019-08-12 개시 Morgan Stanley Overweight
2019-08-12 개시 RBC Capital Mkts Outperform
모두보기

Genmab Adr 주식(GMAB)의 최신 뉴스

pulisher
Oct 20, 2025

Bank of America Upgraded, Allstate Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Oct 20, 2025
pulisher
Oct 20, 2025

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Oct 20, 2025
pulisher
Oct 18, 2025

HC Wainwright Has Pessimistic View of Genmab A/S Q2 Earnings - Defense World

Oct 18, 2025
pulisher
Oct 18, 2025

Genmab A/S’s (GMAB) “Buy” Rating Reiterated at HC Wainwright - Defense World

Oct 18, 2025
pulisher
Oct 16, 2025

Truist Financial Corp Reduces Stock Holdings in Genmab A/S Sponsored ADR $GMAB - Defense World

Oct 16, 2025
pulisher
Oct 16, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Oct 16, 2025
pulisher
Oct 16, 2025

Genmab A/S FY2026 EPS Estimate Reduced by Leerink Partnrs - Defense World

Oct 16, 2025
pulisher
Oct 14, 2025

GMAB or TECH: Which Is the Better Value Stock Right Now? - sharewise.com

Oct 14, 2025
pulisher
Oct 14, 2025

CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight - GlobeNewswire Inc.

Oct 14, 2025
pulisher
Oct 14, 2025

Q3 EPS Estimates for Genmab A/S Lowered by Leerink Partnrs - MarketBeat

Oct 14, 2025
pulisher
Oct 14, 2025

31,681 Shares in Genmab A/S Sponsored ADR $GMAB Purchased by Callan Family Office LLC - MarketBeat

Oct 14, 2025
pulisher
Oct 13, 2025

Walt Disney Upgraded, Southwest Airlines Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Oct 13, 2025
pulisher
Oct 13, 2025

Genmab A/S Sponsored ADR $GMAB Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat

Oct 13, 2025
pulisher
Oct 13, 2025

William Blair Brokers Lift Earnings Estimates for Genmab A/S - MarketBeat

Oct 13, 2025
pulisher
Oct 12, 2025

DAVENPORT & Co LLC Grows Stock Holdings in Genmab A/S Sponsored ADR $GMAB - Defense World

Oct 12, 2025
pulisher
Oct 11, 2025

Wealth Enhancement Advisory Services LLC Buys New Shares in Genmab A/S Sponsored ADR $GMAB - Defense World

Oct 11, 2025
pulisher
Oct 09, 2025

QRG Capital Management Inc. Sells 8,945 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat

Oct 09, 2025
pulisher
Oct 07, 2025

AstraZeneca Upgraded, Home Depot Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Oct 07, 2025
pulisher
Oct 06, 2025

Genmab A/S (NASDAQ:GMAB) Sets New 1-Year HighHere's Why - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

GMAB Stock Soars 21.9% in a Month Following MRUS Acquisition Deal - sharewise.com

Oct 06, 2025
pulisher
Oct 04, 2025

Genmab AS (GMAB) Stock Price, Trades & News - GuruFocus

Oct 04, 2025
pulisher
Oct 03, 2025

What Makes Genmab A/S Sponsored ADR (GMAB) a Strong Momentum Stock: Buy Now? - sharewise.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why Genmab Stock Popped on Friday - The Globe and Mail

Oct 03, 2025
pulisher
Oct 03, 2025

Leerink Partnrs Weighs in on Genmab A/S FY2027 Earnings - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

Best Momentum Stock to Buy for October 3rd - sharewise.com

Oct 03, 2025
pulisher
Oct 03, 2025

Genmab A/S (NASDAQ:GMAB) Price Target Raised to $40.00 at HC Wainwright - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

Genmab A/S Sponsored ADR $GMAB Stock Position Lowered by Signaturefd LLC - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

New Strong Buy Stocks for October 3rd - Yahoo Finance

Oct 03, 2025
pulisher
Oct 02, 2025

Leerink Partnrs Comments on Genmab A/S FY2027 Earnings - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Genmab A/S Updates Articles of Association to Enhance Growth Strategy - The Globe and Mail

Oct 01, 2025
pulisher
Oct 01, 2025

FY2025 EPS Estimates for Genmab A/S Boosted by William Blair - MarketBeat

Oct 01, 2025
pulisher
Oct 01, 2025

Park Avenue Securities LLC Acquires 832 Shares of Genmab A/S Sponsored ADR $GMAB - Defense World

Oct 01, 2025
pulisher
Sep 30, 2025

TD Cowen Remains a Hold on Genmab (GMAB) - The Globe and Mail

Sep 30, 2025
pulisher
Sep 30, 2025

Genmab A/S (NASDAQ:GMAB) Sets New 52-Week HighWhat's Next? - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

TD Private Client Wealth LLC Has $130,000 Stock Holdings in Genmab A/S Sponsored ADR $GMAB - Defense World

Sep 30, 2025
pulisher
Sep 30, 2025

Genmab A/S (NASDAQ:GMAB) Sees Strong Trading Volume on Analyst Upgrade - Defense World

Sep 30, 2025
pulisher
Sep 29, 2025

Genmab A/S (NASDAQ:GMAB) Sees Large Volume Increase After Analyst Upgrade - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Trending tickers: Alibaba, AstraZeneca, GSK, Stellantis and Genmab - Yahoo

Sep 29, 2025
pulisher
Sep 29, 2025

European Stocks Higher to Kick Off the Week - TradingView

Sep 29, 2025
pulisher
Sep 29, 2025

Genmab A/S Sponsored ADR $GMAB Shares Sold by Fifth Third Bancorp - Defense World

Sep 29, 2025
pulisher
Sep 29, 2025

Before the bell: futures up, Lufthansa cuts jobs, GSK CEO steps down - TradingView

Sep 29, 2025
pulisher
Sep 29, 2025

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model - Placera.se

Sep 29, 2025
pulisher
Sep 25, 2025

Genmab A/S (NASDAQ:GMAB) Upgraded by Guggenheim to Buy Rating - Defense World

Sep 25, 2025
pulisher
Sep 25, 2025

Genmab A/S Sponsored ADR $GMAB Shares Purchased by Parallel Advisors LLC - Defense World

Sep 25, 2025
pulisher
Sep 25, 2025

Rhumbline Advisers Increases Stock Holdings in Genmab A/S Sponsored ADR $GMAB - Defense World

Sep 25, 2025

Genmab Adr (GMAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$89.31
price up icon 1.42%
$36.85
price up icon 0.03%
$104.75
price down icon 1.39%
$160.12
price down icon 0.17%
biotechnology ONC
$310.03
price down icon 1.12%
자본화:     |  볼륨(24시간):